Literature DB >> 18460072

Inhalation of Stachybotrys chartarum causes pulmonary arterial hypertension in mice.

Eri Ochiai1, Katsuhiko Kamei, Akira Watanabe, Masaru Nagayoshi, Yuji Tada, Tetsutaro Nagaoka, Koichi Sato, Ayaka Sato, Kazutoshi Shibuya.   

Abstract

Inhalation of Stachybotrys chartarum, a ubiquitous fungus in our living environment, has been suspected as a cause of acute idiopathic pulmonary haemorrhage in infants, but its relation to human diseases is not yet known. The aim of present study was to investigate the effect of repeated intratracheal injection of the fungus into mice, paying special attention to the pulmonary vascular system. Spores of S. chartarum were injected into the trachea of mice from 6 to 18 times over 4-12 weeks, and the lungs were examined by histopathology, morphometrics and haemodynamics. When 1 x 10(4) spores/mouse were injected, histopathological examination showed the development of pulmonary arterial hypertension (PAH). Symmetrical thickening of the intima and media of the pulmonary arterial walls was seen after six injections over 4 weeks. Right ventricular hypertrophy was also evident after 12 injections. PAH was confirmed by the elevation of right ventricular systolic pressure (20.1 +/- 5.7 mmHg in the injected group vs. 12.0 +/- 2.4 mmHg in the control group, P < 0.01). This study showed that the inhalation of S. chartarum caused PAH in mice, suggesting a potential of S. chartarum as a cause of human health problem such as PAH.

Entities:  

Mesh:

Year:  2008        PMID: 18460072      PMCID: PMC2525769          DOI: 10.1111/j.1365-2613.2008.00585.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  28 in total

1.  Update: pulmonary hemorrhage/hemosiderosis among infants--Cleveland, Ohio, 1993-1996.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-01-17       Impact factor: 17.586

2.  The rat is a poor animal model for the study of human pulmonary hypertension.

Authors:  D Heath
Journal:  Cardioscience       Date:  1992-03

3.  Granulocyte colony-stimulating factor prevents progression of monocrotaline-induced pulmonary arterial hypertension in rats.

Authors:  Hidekazu Maruyama; Shigeyuki Watanabe; Taizo Kimura; Jingyan Liang; Toshiro Nagasawa; Masafumi Onodera; Kazutaka Aonuma; Iwao Yamaguchi
Journal:  Circ J       Date:  2007-01       Impact factor: 2.993

4.  Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.

Authors:  Masahiko Oka; Noriyuki Homma; Laimute Taraseviciene-Stewart; Kenneth G Morris; Donatas Kraskauskas; Nana Burns; Norbert F Voelkel; Ivan F McMurtry
Journal:  Circ Res       Date:  2007-03-01       Impact factor: 17.367

Review 5.  A review of tribromoethanol anesthesia for production of genetically engineered mice and rats.

Authors:  Robert E Meyer; Richard E Fish
Journal:  Lab Anim (NY)       Date:  2005-11       Impact factor: 12.625

6.  Nocistatin, a peptide that blocks nociceptin action in pain transmission.

Authors:  E Okuda-Ashitaka; T Minami; S Tachibana; Y Yoshihara; Y Nishiuchi; T Kimura; S Ito
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

7.  Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.

Authors:  Christophe Guignabert; Mohamed Izikki; Ly Ieng Tu; Zhenlin Li; Patricia Zadigue; Anne-Marie Barlier-Mur; Naïma Hanoun; David Rodman; Michel Hamon; Serge Adnot; Saadia Eddahibi
Journal:  Circ Res       Date:  2006-04-13       Impact factor: 17.367

Review 8.  Primary pulmonary hypertension.

Authors:  S P Gaine; L J Rubin
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

9.  Trichothecene mycotoxins in aerosolized conidia of Stachybotrys atra.

Authors:  W G Sorenson; D G Frazer; B B Jarvis; J Simpson; V A Robinson
Journal:  Appl Environ Microbiol       Date:  1987-06       Impact factor: 4.792

10.  Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle.

Authors:  James West; Karen Fagan; Wolfgang Steudel; Brian Fouty; Kirk Lane; Julie Harral; Marloes Hoedt-Miller; Yuji Tada; John Ozimek; Rubin Tuder; David M Rodman
Journal:  Circ Res       Date:  2004-03-18       Impact factor: 17.367

View more
  9 in total

1.  Cultivation and aerosolization of Stachybotrys chartarum for modeling pulmonary inhalation exposure.

Authors:  Angela R Lemons; Tara L Croston; W Travis Goldsmith; Mark A Barnes; Mukhtar A Jaderson; Ju-Hyeong Park; Walter McKinney; Donald H Beezhold; Brett J Green
Journal:  Inhal Toxicol       Date:  2019-12-24       Impact factor: 2.724

2.  Guest editorial--novel insights into the pathology of Stachybotrys chartarum.

Authors:  Iwona Yike; Dorr Dearborn
Journal:  Mycopathologia       Date:  2011-04-20       Impact factor: 2.574

3.  Identification of Fusarium species in formalin-fixed and paraffin-embedded sections by in situ hybridization using peptide nucleic acid probes.

Authors:  Minoru Shinozaki; Yoichiro Okubo; Daisuke Sasai; Haruo Nakayama; Somay Yamagata Murayama; Tadashi Ide; Megumi Wakayama; Nobuyuki Hiruta; Kazutoshi Shibuya
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

4.  Inhalation of Stachybotrys chartarum evokes pulmonary arterial remodeling in mice, attenuated by Rho-kinase inhibitor.

Authors:  Masaru Nagayoshi; Yuji Tada; James West; Eri Ochiai; Akira Watanabe; Takahito Toyotome; Nobuhiro Tanabe; Yuichi Takiguchi; Ayako Shigeta; Tadashi Yasuda; Kazutoshi Shibuya; Katsuhiko Kamei; Koichiro Tatsumi
Journal:  Mycopathologia       Date:  2011-04-20       Impact factor: 2.574

5.  Preventive aerobic training exerts a cardioprotective effect on rats treated with monocrotaline.

Authors:  Francis Lopes Pacagnelli; Ana Karênina Dias de Almeida Sabela; Katashi Okoshi; Thaoan Bruno Mariano; Dijon Henrique Salomé Campos; Robson Francisco Carvalho; Antônio Carlos Cicogna; Luiz Carlo Marques Vanderlei
Journal:  Int J Exp Pathol       Date:  2016-07-01       Impact factor: 1.925

6.  Repeated Mouse Lung Exposures to Stachybotrys chartarum Shift Immune Response from Type 1 to Type 2.

Authors:  Jamie H Rosenblum Lichtenstein; Ramon M Molina; Thomas C Donaghey; Yi-Hsiang H Hsu; Joel A Mathews; David I Kasahara; Jin-Ah Park; André Bordini; John J Godleski; Bruce S Gillis; Joseph D Brain
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914

7.  Inhalation of Stachybotrys chartarum Fragments Induces Pulmonary Arterial Remodeling.

Authors:  Tara L Croston; Angela R Lemons; Mark A Barnes; William T Goldsmith; Marlene S Orandle; Ajay P Nayak; Dori R Germolec; Brett J Green; Donald H Beezhold
Journal:  Am J Respir Cell Mol Biol       Date:  2020-05       Impact factor: 6.914

8.  Implication of overexpression of dishevelled-associated activator of morphogenesis 1 (Daam-1) for the pathogenesis of human Idiopathic Pulmonary Arterial Hypertension (IPAH).

Authors:  Shun Yanai; Megumi Wakayama; Haruo Nakayama; Minoru Shinozaki; Hisayuki Tsukuma; Naobumi Tochigi; Tetsuo Nemoto; Tsutomu Saji; Kazutoshi Shibuya
Journal:  Diagn Pathol       Date:  2017-03-14       Impact factor: 2.644

9.  Gene expression analysis of a murine model with pulmonary vascular remodeling compared to end-stage IPAH lungs.

Authors:  Kayoko Shimodaira; Yoichiro Okubo; Eri Ochiai; Haruo Nakayama; Harutaka Katano; Megumi Wakayama; Minoru Shinozaki; Takao Ishiwatari; Daisuke Sasai; Naobumi Tochigi; Tetsuo Nemoto; Tsutomu Saji; Katsuhiko Kamei; Kazutoshi Shibuya
Journal:  Respir Res       Date:  2012-11-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.